Handel nachbörslich: 4.82

Inozyme Pharma Inc (INZY)

Inozyme Pharma Inc Aktie (INZY) Neueste Nachrichten

Inozyme Pharma Inc (INZY)

Inozyme Pharma Inc Aktie (INZY) Neueste Nachrichten

Wells Fargo Initiates Coverage of Inozyme Pharma (INZY) with Overweight Recommendation - MSN

Inozyme Pharma stock rated Overweight by Wells Fargo, highlighting rare disease focus By Investing.com - Investing.com

Wells Fargo Initiates Coverage of Inozyme Pharma (INZY) with Overweight Recommendation - MSN

Inozyme Pharma (NASDAQ:INZY) Research Coverage Started at Wells Fargo & Company - MarketBeat

Inozyme Pharma to Present at the Jefferies Global Healthcare Conference - Yahoo Finance Australia

Inozyme Pharma Inc (INZY)'s stock price range in the last year – US Post News - US Post News

Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 ... - GlobeNewswire

Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences

Why Earnings Season Could Be Great for Inozyme (INZY) - Yahoo Canada Shine On

Why Earnings Season Could Be Great for Inozyme (INZY) - Yahoo Canada Shine On

Needham Reiterates Inozyme Pharma (INZY) Buy Recommendation - MSN

Short Interest in Inozyme Pharma, Inc. (NASDAQ:INZY) Increases By 7.6% - MarketBeat

Inozyme Pharma, Inc. (NASDAQ:INZY) Sees Significant Increase in Short Interest - Defense World

Short Interest in Inozyme Pharma, Inc. (NASDAQ:INZY) Increases By 7.6% - MarketBeat

Inozyme Pharma (NASDAQ:INZY) Receives “Buy” Rating from Needham & Company LLC - Defense World

Q2 2024 Earnings Estimate for Inozyme Pharma, Inc. Issued By HC Wainwright (NASDAQ:INZY) - MarketBeat

Wedbush Weighs in on Inozyme Pharma, Inc.'s Q1 2025 Earnings (NASDAQ:INZY) - MarketBeat

Needham & Company LLC Reiterates Buy Rating for Inozyme Pharma (NASDAQ:INZY) - MarketBeat

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference - Yahoo Finance

Inozyme Pharma's (INZY) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference - Yahoo Finance

Inozyme Pharma's (INZY) Outperform Rating Reaffirmed at Wedbush - MarketBeat

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights - Yahoo Finance

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights - Yahoo Finance

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Ratios Reveal: Breaking Down Inozyme Pharma Inc (INZY)'s Financial Health – DWinneX - The Dwinnex

Ratios Reveal: Breaking Down Inozyme Pharma Inc (INZY)'s Financial Health – DWinneX - The Dwinnex

Inozyme Pharma Inc (INZY) presents a great opportunity, but the stock is slightly undervalued – US Post News - US Post News

Inozyme Pharma (NASDAQ:INZY) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Inozyme Pharma stock target cut, maintains Buy rating By Investing.com - Investing.com Nigeria

BofA cuts Inozyme Pharma stock target, maintains buy rating - Investing.com Nigeria

BofA cuts Inozyme Pharma stock target, maintains buy rating - Investing.com

Inozyme Pharma Advances with Promising INZ-701 Trial Results - TipRanks.com - TipRanks

Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency

Inozyme reports positive trial data for rare disease treatments By Investing.com - Investing.com

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference

Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewswire

Top 5 Health Care Stocks That May Plunge In March

Top 5 Health Care Stocks That May Plunge In March - Mesoblast (NASDAQ:MESO), Inozyme Pharma (NASDAQ:INZY) - Benzinga

Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024

Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency ... - GlobeNewswire

Soojin Kim | People on The Move - Boston Business Journal - The Business Journals

Katie Swanner | People on The Move - Boston Business Journal - The Business Journals

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights - Yahoo Finance

Ähnlich wie INZY